Angela Neubauer

Title: Angela Neubauer: Innovator in Allergy Treatment

Introduction

Angela Neubauer is a prominent inventor based in Maria Anzbach, Austria. She has made significant contributions to the field of allergy treatment through her innovative research and development. Her work focuses on hypoallergenic hybrid polypeptides, which have the potential to revolutionize the way allergies are treated.

Latest Patents

Angela Neubauer holds a patent for "Hypoallergenic hybrid polypeptides for the treatment of allergy." This invention relates to a method for identifying hypoallergenic polypeptides and includes a corresponding screening method. The invention also encompasses the prophylactic and therapeutic use of these identified polypeptides. She has 1 patent to her name, showcasing her dedication to advancing medical science.

Career Highlights

Throughout her career, Angela has been associated with Biomay AG, a company known for its innovative approaches in biotechnology. Her work at Biomay AG has allowed her to explore new frontiers in allergy treatment, contributing to the development of safer and more effective therapeutic options.

Collaborations

Angela Neubauer has collaborated with notable colleagues in her field, including Rudolf Valenta and Birgit Linhart. These partnerships have enhanced her research and expanded the impact of her inventions in the scientific community.

Conclusion

Angela Neubauer is a trailblazer in the field of allergy treatment, with her innovative work on hypoallergenic polypeptides paving the way for future advancements. Her contributions are vital in improving the lives of those affected by allergies.